A subtype of cancer-associated fibroblast expressing syndecan-2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer

Cited 0 times in

DC Field	Value	Language
dc.contributor.author	정재호	-
dc.date.accessioned	2025-04-17T08:20:34Z	-
dc.date.available	2025-04-17T08:20:34Z	-
dc.date.issued	2024-12	-
dc.identifier.uri	https://ir.ymlib.yonsei.ac.kr/handle/22282913/204572	-
dc.description.statementOfResponsibility	open	-
dc.language	English	-
dc.publisher	Wiley	-
dc.relation.isPartOf	CLINICAL AND TRANSLATIONAL MEDICINE	-
dc.rights	CC BY-NC-ND 2.0 KR	-
dc.title	A subtype of cancer-associated fibroblast expressing syndecan-2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer	-
dc.type	Article	-
dc.contributor.college	College of Medicine (의과대학)	-
dc.contributor.department	Dept. of Surgery (외과학교실)	-
dc.contributor.googleauthor	Ji-Yong Sung	-
dc.contributor.googleauthor	Jae-Ho Cheong	-
dc.contributor.googleauthor	Kihye Shin	-
dc.contributor.googleauthor	Eui Tae Kim	-
dc.identifier.doi	10.1002/ctm2.70079	-
dc.contributor.localId	A03717	-
dc.relation.journalcode	J04026	-
dc.identifier.eissn	2001-1326	-
dc.identifier.pmid	39673118	-
dc.contributor.alternativeName	Cheong, Jae Ho	-
dc.contributor.affiliatedAuthor	정재호	-
dc.citation.volume	14	-
dc.citation.number	12	-
dc.citation.startPage	e70079	-
dc.identifier.bibliographicCitation	CLINICAL AND TRANSLATIONAL MEDICINE, Vol.14(12) : e70079, 2024-12	-

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

Show simple item record

YUHSpace: A subtype of cancer-associated fibroblast expressing syndecan-2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer